Sanofi to buy 12 percent of Alnylam, expands rare-disease drug deal

Sanofi to buy 12 percent of Alnylam, expands rare-disease drug deal

An employee walks into an office of French drugmaker Sanofi in Shanghai August 2, 2013.

Credit: Reuters/Aly Song

Read the original here:
feeds.reuters

Healthy Living News From around The Web
Sanofi to buy 12 percent of Alnylam, expands rare-disease drug deal – Reuters

Google+

Dopps Chiropractic
4746 S. Broadway
WichitaKs 67216

(316) 522-1122
http://DoppsChiropracticSouth.com

Leave a comment